HARP - Harpoon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Merck
2024-03-05 10:53:38 ET
More on Harpoon Therapeutics
- Harpoon Therapeutics ticks higher after HSR waiting period for Merck deal expires
- Harpoon Therapeutics could see interest from other parties, Oppenheimer says
- Seeking Alpha’s Quant Rating on Harpoon Therapeutics
- Historical earnings data for Harpoon Therapeutics
- Financial information for Harpoon Therapeutics